A detailed history of West End Advisors, LLC transactions in Medtronic PLC stock. As of the latest transaction made, West End Advisors, LLC holds 491,159 shares of MDT stock, worth $40 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
491,159
Previous 484,043 1.47%
Holding current value
$40 Million
Previous $38.1 Million 16.06%
% of portfolio
1.09%
Previous 0.98%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$76.84 - $91.03 $546,793 - $647,769
7,116 Added 1.47%
491,159 $44.2 Million
Q2 2024

Jul 29, 2024

BUY
$78.71 - $87.02 $6.79 Million - $7.51 Million
86,268 Added 21.69%
484,043 $38.1 Million
Q1 2024

May 07, 2024

BUY
$82.84 - $88.09 $514,436 - $547,038
6,210 Added 1.59%
397,775 $34.7 Million
Q4 2023

Jan 18, 2024

SELL
$69.43 - $83.43 $745,747 - $896,121
-10,741 Reduced 2.67%
391,565 $32.3 Million
Q3 2023

Oct 19, 2023

SELL
$78.22 - $90.4 $1.1 Million - $1.27 Million
-14,024 Reduced 3.37%
402,306 $31.5 Million
Q2 2023

Jul 21, 2023

SELL
$79.47 - $91.38 $16,847 - $19,372
-212 Reduced 0.05%
416,330 $36.7 Million
Q1 2023

Apr 28, 2023

BUY
$76.72 - $87.58 $5.41 Million - $6.18 Million
70,538 Added 20.39%
416,542 $33.6 Million
Q4 2022

Jan 31, 2023

SELL
$76.18 - $87.74 $3.86 Million - $4.44 Million
-50,660 Reduced 12.77%
346,004 $26.9 Million
Q3 2022

Oct 27, 2022

SELL
$80.75 - $95.31 $447,839 - $528,589
-5,546 Reduced 1.38%
396,664 $32 Million
Q2 2022

Jul 28, 2022

SELL
$87.4 - $113.09 $491,100 - $635,452
-5,619 Reduced 1.38%
402,210 $36.1 Billion
Q1 2022

Apr 26, 2022

BUY
$100.58 - $112.38 $5.06 Million - $5.66 Million
50,347 Added 14.08%
407,829 $45.2 Billion
Q4 2021

Jan 14, 2022

BUY
$99.53 - $127.75 $203,339 - $260,993
2,043 Added 0.57%
357,482 $37 Billion
Q3 2021

Oct 26, 2021

BUY
$122.75 - $135.17 $50,204 - $55,284
409 Added 0.12%
355,439 $44.6 Billion
Q2 2021

Jul 15, 2021

BUY
$118.19 - $131.5 $1.53 Million - $1.7 Million
12,964 Added 3.79%
355,030 $44.1 Billion
Q1 2021

Apr 27, 2021

BUY
$111.18 - $119.74 $910,786 - $980,910
8,192 Added 2.45%
342,066 $40.4 Billion
Q4 2020

Jan 28, 2021

SELL
$100.57 - $117.14 $1.2 Million - $1.4 Million
-11,919 Reduced 3.45%
333,874 $39.1 Billion
Q3 2020

Oct 22, 2020

BUY
$90.13 - $108.78 $610,360 - $736,658
6,772 Added 2.0%
345,793 $35.9 Billion
Q2 2020

Jul 22, 2020

BUY
$84.11 - $103.33 $2.79 Million - $3.42 Million
33,137 Added 10.83%
339,021 $31.1 Billion
Q1 2020

May 05, 2020

SELL
$72.92 - $121.3 $228,093 - $379,426
-3,128 Reduced 1.01%
305,884 $27.6 Billion
Q4 2019

Feb 12, 2020

SELL
$104.49 - $114.54 $1.92 Million - $2.11 Million
-18,391 Reduced 5.62%
309,012 $35.1 Billion
Q3 2019

Nov 07, 2019

SELL
$98.02 - $111.18 $2.01 Million - $2.28 Million
-20,545 Reduced 5.9%
327,403 $35.6 Billion
Q2 2019

Jul 23, 2019

SELL
$84.15 - $99.38 $3.59 Million - $4.24 Million
-42,651 Reduced 10.92%
347,948 $33.9 Billion
Q1 2019

May 03, 2019

BUY
$82.45 - $93.79 $862,097 - $980,668
10,456 Added 2.75%
390,599 $35.6 Billion
Q4 2018

Jan 30, 2019

SELL
$85.8 - $99.49 $4.25 Million - $4.93 Million
-49,528 Reduced 11.53%
380,143 $34.6 Billion
Q3 2018

Nov 07, 2018

SELL
$85.91 - $99.17 $883,842 - $1.02 Million
-10,288 Reduced 2.34%
429,671 $42.3 Billion
Q2 2018

Jul 26, 2018

SELL
$77.48 - $87.83 $7.85 Million - $8.89 Million
-101,255 Reduced 18.71%
439,959 $37.7 Billion
Q1 2018

May 08, 2018

SELL
$76.55 - $87.26 $369,889 - $421,640
-4,832 Reduced 0.88%
541,214 $43.4 Billion
Q4 2017

Feb 02, 2018

SELL
$76.93 - $83.5 $1.89 Million - $2.05 Million
-24,579 Reduced 4.31%
546,046 $44.1 Billion
Q3 2017

Nov 03, 2017

SELL
$77.71 - $84.6 $4.95 Million - $5.39 Million
-63,710 Reduced 10.04%
570,625 $44.4 Billion
Q2 2017

Aug 09, 2017

BUY
N/A
634,335
634,335 $56.3 Billion

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.